These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1425790)

  • 1. Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic central precocious puberty.
    Brauner R; Malandry F; Rappaport R
    Eur J Pediatr; 1992 Oct; 151(10):728-30. PubMed ID: 1425790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs.
    Lanes R; Soros A; Jakubowicz S
    J Pediatr Endocrinol Metab; 2004 May; 17(5):759-66. PubMed ID: 15237711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
    Bertelloni S; Baroncelli GI; Sorrentino MC; Perri G; Saggese G
    Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement of expected and final height in girls with central precocious puberty treated with gonadotropin releasing hormone analogues].
    Gómez F; Picó AM; Vargas F; Mauri M
    Med Clin (Barc); 1996 Nov; 107(18):681-4. PubMed ID: 9082075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ; Hümmelink R; Peter M; Sippell WG; Oostdijk W; Odink RJ; Drop SL
    Horm Res; 1993; 39(3-4):111-7. PubMed ID: 8262471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
    Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results with a slow-release gonadotrophin-releasing hormone agonist in central precocious puberty. Dutch-German Precocious Puberty Study Group.
    Oostdijk W; Drop SL; Odink RJ; Hümmelink R; Partsch CJ; Sippell WG
    Acta Paediatr Scand Suppl; 1991; 372():39-45; discussion 46. PubMed ID: 1833950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment.
    Adan L; Chemaitilly W; Trivin C; Brauner R
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):297-302. PubMed ID: 11940040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult height in girls with idiopathic true precocious puberty.
    Brauner R; Adan L; Malandry F; Zantleifer D
    J Clin Endocrinol Metab; 1994 Aug; 79(2):415-20. PubMed ID: 8045957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
    Lazar L; Kauli R; Pertzelan A; Phillip M
    J Clin Endocrinol Metab; 2002 May; 87(5):2090-4. PubMed ID: 11994346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.
    Bertelloni S; Baroncelli GI; Ferdeghini M; Menchini-Fabris F; Saggese G
    Eur J Pediatr; 2000 May; 159(5):369-74. PubMed ID: 10834524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with LHRH analogues in girls with precocious puberty does not improve final height. Longitudinal study compared with a control group].
    Llop-Viñolas D; Vizmanos-Lamotte B; Aresté-Piztzalis A; Fernández-Ballart J; Martí-Henneberg C
    Med Clin (Barc); 2001 Jun; 117(4):124-8. PubMed ID: 11472683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
    Brito VN; Latronico AC; Cukier P; Teles MG; Silveira LF; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic precocious puberty versus puberty in adopted children; auxological response to gonadotrophin-releasing hormone agonist treatment and final height.
    Kempers MJ; Otten BJ
    Eur J Endocrinol; 2002 Nov; 147(5):609-16. PubMed ID: 12444892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy.
    Kauli R; Kornreich L; Laron Z
    Horm Res; 1990; 33(1):11-7. PubMed ID: 2142928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.